B 07Alternative Names: Fenozan 50
Latest Information Update: 03 Sep 2002
At a glance
- Originator Nonindustrial source
- Developer PharmaMar
- Class Antimalarials
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Malaria in Spain (Unknown route)